Distinct Proteasomal Pathways Drive Oncogenic PPM1D Activation
Ni Yan, Deumaya Shrestha, Cameron Schluter…·Peter Grant Miller
This study shows that truncating mutations in PPM1D shift its degradation pathway from ubiquitin-independent to UBR5-mediated, leading to increased PPM1D levels and oncogenic effects.